Twin Capital Management Inc. Sells 547 Shares of MetLife, Inc. (NYSE:MET)

Twin Capital Management Inc. trimmed its stake in MetLife, Inc. (NYSE:MET) by 1.3% in the 4th quarter, Holdings Channel.com reports. The firm owned 42,114 shares of the financial services provider’s stock after selling 547 shares during the period. Twin Capital Management Inc.’s holdings in MetLife were worth $2,785,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. IHT Wealth Management LLC lifted its holdings in shares of MetLife by 4.5% in the 4th quarter. IHT Wealth Management LLC now owns 3,466 shares of the financial services provider’s stock valued at $251,000 after buying an additional 150 shares during the period. Carolinas Wealth Consulting LLC lifted its holdings in shares of MetLife by 26.4% in the 1st quarter. Carolinas Wealth Consulting LLC now owns 767 shares of the financial services provider’s stock valued at $54,000 after buying an additional 160 shares during the period. Harbour Investments Inc. lifted its holdings in shares of MetLife by 3.2% in the 4th quarter. Harbour Investments Inc. now owns 5,269 shares of the financial services provider’s stock valued at $381,000 after buying an additional 162 shares during the period. Eley Financial Management Inc lifted its holdings in shares of MetLife by 1.0% in the 3rd quarter. Eley Financial Management Inc now owns 16,348 shares of the financial services provider’s stock valued at $1,028,000 after buying an additional 168 shares during the period. Finally, Austin Private Wealth LLC lifted its holdings in shares of MetLife by 4.1% in the 4th quarter. Austin Private Wealth LLC now owns 4,367 shares of the financial services provider’s stock valued at $289,000 after buying an additional 170 shares during the period. 89.81% of the stock is owned by institutional investors.

Insider Activity

In other news, insider Ramy Tadros sold 4,026 shares of the company’s stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total value of $289,469.40. Following the completion of the sale, the insider now directly owns 146,981 shares in the company, valued at $10,567,933.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, insider Ramy Tadros sold 4,026 shares of the company’s stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total value of $289,469.40. Following the completion of the sale, the insider now directly owns 146,981 shares in the company, valued at $10,567,933.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Bill Pappas sold 27,000 shares of the company’s stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $72.27, for a total value of $1,951,290.00. Following the completion of the transaction, the executive vice president now owns 57,768 shares in the company, valued at $4,174,893.36. The disclosure for this sale can be found here. Company insiders own 0.32% of the company’s stock.

Analyst Upgrades and Downgrades

MET has been the subject of a number of analyst reports. UBS Group reduced their price target on MetLife from $87.00 to $82.00 and set a “buy” rating for the company in a report on Monday, February 5th. Keefe, Bruyette & Woods upped their price target on MetLife from $82.00 to $87.00 and gave the stock an “outperform” rating in a report on Wednesday, April 10th. Morgan Stanley upped their price target on MetLife from $80.00 to $82.00 and gave the stock an “overweight” rating in a report on Monday. Wells Fargo & Company upped their price target on MetLife from $83.00 to $86.00 and gave the stock an “overweight” rating in a report on Thursday, April 11th. Finally, The Goldman Sachs Group raised MetLife from a “neutral” rating to a “buy” rating and upped their price target for the stock from $70.00 to $80.00 in a report on Monday, January 8th. Two research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $79.23.

MetLife Price Performance

NYSE:MET traded up $0.79 during trading hours on Thursday, hitting $69.71. 846,299 shares of the stock were exchanged, compared to its average volume of 3,536,356. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.53. The firm’s fifty day moving average price is $70.98 and its 200 day moving average price is $66.68. The company has a market cap of $50.40 billion, a P/E ratio of 37.66, a P/E/G ratio of 0.52 and a beta of 1.04. MetLife, Inc. has a 52-week low of $48.95 and a 52-week high of $74.68.

MetLife (NYSE:MET) last posted its quarterly earnings results on Wednesday, January 31st. The financial services provider reported $1.93 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.95 by ($0.02). The company had revenue of $18.72 billion during the quarter, compared to analysts’ expectations of $18.07 billion. MetLife had a net margin of 2.36% and a return on equity of 19.48%. As a group, equities research analysts anticipate that MetLife, Inc. will post 8.71 EPS for the current fiscal year.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.